Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube
SUBSCRIBE

Overcoming Hurdles to Optimal Care for Patients with NTM-LD

Program Overview

In this activity, a panel of experts discuss current guidelines and best practices for the management of nontuberculous mycobacterial lung disease (NTM-LD), including treatment options for refractory disease and strategies for minimizing adverse effects of therapies. An experienced patient with NTM-LD shares her experiences with oral and inhaled therapies and how she overcame treatment challenges.

Credit Expired
0.50 CE Credit(s)
Expires: August 16, 2022

Target Audience

This activity is intended for pulmonology, infectious disease, internal medicine clinicians, and other healthcare professionals involved in the treatment of patients with nontuberculous mycobacterial lung disease (NTM-LD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Employ current data, guidelines, and best practices when managing individuals with nontuberculous mycobacterial lung disease (NTM-LD)
  • Apply strategies to maintain adherence and address treatment-related adverse effects in patients with NTM-LD

Activity Faculty

flume_headshot_small

Patrick A. Flume, MD

Professor, Medicine and Pediatrics
Medical University of South Carolina
Charleston, SC

Addrizzo-Harris_300x400

Doreen J. Addrizzo-Harris, MD

Professor of Medicine
Associate Director, Clinical and Academic Affairs
Director, NYU Bronchiectasis/NTM Program
NYU Grossman School of Medicine
New York, NY

Philley_300x400

Julie V. Philley, MD

Executive Vice President, Health Affairs
University of Texas Health Science Center at Tyler
Tyler, TX

Featured RMEI CE Activities

Copyright © 2023. RMEI Medical Education, LLC. All rights reserved​

Privacy | Terms of Use

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources